D
Daniel P. Schuster
Researcher at Washington University in St. Louis
Publications - 148
Citations - 7618
Daniel P. Schuster is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Lung injury & Lung. The author has an hindex of 48, co-authored 148 publications receiving 7445 citations. Previous affiliations of Daniel P. Schuster include American Heart Association & Barnes-Jewish Hospital.
Papers
More filters
Journal ArticleDOI
Improved Outcome Based on Fluid Management in Critically III Patients Requiring Pulmonary Artery Catheterization
TL;DR: A lower positive fluid balance, especially in patients with pulmonary edema regardless of cause, is associated with reduced EVLW, ventilator-days, and ICU days, as well as time on mechanical ventilation and time in the intensive care unit (ICU), in critically ill patients requiring pulmonary artery catheterization.
Journal ArticleDOI
The Acute Respiratory Distress Syndrome
TL;DR: New strategies for administering mechanical ventilation to patients with ARDS may reduce the occurrence of iatrogenic volotrauma and oxygen toxicity, accounting in part for the recently observed improvements in patient survival.
Journal ArticleDOI
Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients
TL;DR: It is suggested that PA catheterization is both indicated and useful in the management of critically ill patients because of the difficulty of predicting accurately hemodynamics based solely on clinical evaluation.
Journal ArticleDOI
Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death
Anthony P. Khalifah,Ramsey R. Hachem,Murali M. Chakinala,Kenneth B. Schechtman,G. Alexander Patterson,Daniel P. Schuster,Thalachallour Mohanakumar,Elbert P. Trulock,Michael J. Walter +8 more
TL;DR: Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post- CARV BOS.